Ichor Holdings, Ltd. (ICHR) provides critical fluid delivery subsystems and precision components for semiconductor capital equipment. The company specializes in parts essential for manufacturing processes such as etch, deposition, and cleaning, supplying major original equipment manufacturers (OEMs) in the semiconductor space. Operating firmly in the technology sector—particularly semiconductor equipment and materials—ICHR delivers focused exposure to the cyclical semiconductor supply chain.
Unlike diversified ETFs, ICHR generates revenue mainly from gas, chemical delivery, and machined components for semi OEMs like AMAT and LRCX. This targeted reliance on WFE demand goes a long way in explaining its recent price action, as increases in chip production capacity directly enhance its order book and revenue prospects.
In the last 30 days, Ichor Holdings, Ltd. (ICHR) advanced +58%, climbing from about $42 to $66.54. The move was trend-based with moderate volatility, showing steady gains through April and peaking above $70 before a slight retreat. I also checked this using Tickeron’s AI Screener to compare it against peers in the sector.
Over the quarter, ICHR posted a +99% gain, rising from roughly $33 to current levels. Momentum built strongly from early-year lows during the sector recovery, with higher volume on up days and less sideways action.
The +58% rise in ICHR over the past 30 days reflects growing investor confidence in semiconductor equipment. Standout catalysts were analyst upgrades, including Stifel's Buy rating with a $55 target in March, alongside industry tailwinds from elevated WFE spending tied to AI chip demand.
Peers in semiconductors also advanced, boosting ICHR as its fluid delivery systems tie directly to rising capital equipment orders. Positive sentiment around preliminary Q4 2025 results and Q1 2026 guidance of at least $240 million in revenue added fuel. With institutional ownership above 100%, the rally held firm without notable selling pressure. The stock's beta of 1.67 underscores its link to sector moves, tying OEM capex expansion to ICHR's appreciation.
ICHR's +99% quarterly advance came from a semiconductor rebound, with global sales expected to reach record highs in 2026 on AI and data center growth. Broader trends like WFE recovery after the downturn and projections for $1.3 trillion in sector revenue by 2026 built sustained support.
Macro tailwinds from ongoing tech expansion overshadowed earlier inventory issues. Institutional buying, with BlackRock and Vanguard holding over 24% combined, bolstered the uptrend. ICHR outpaced the semiconductor equipment industry, which posted solid but less dramatic gains, thanks to demand for its specialized components from top OEMs.
One tool I find invaluable for dissecting stocks like ICHR is Tickeron’s AI Screener. This AI-powered platform lets me scan thousands of stocks and ETFs using filters for technical patterns, fundamentals, trends, volatility, and AI signals—such as industry, market cap, indicators, price patterns, and performance metrics. It uncovers trade ideas, breakouts, and opportunities far faster than manual reviews, helping refine my strategy. From what I see, it's a practical way to stay ahead in this fast-moving sector.
Keep an eye on the semiconductor outlook, especially WFE trends and AI infrastructure spending. Q1 2026 earnings on May 4 will shed light on revenue and margins. Monitor key OEM customers like AMAT and LRCX for demand cues. Broader factors include interest rates affecting tech capex and global chip supply dynamics. Risks center on cyclical slowdowns or order delays, while upsides may come from analyst updates or sector M&A.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The 10-day RSI Indicator for ICHR moved out of overbought territory on April 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on April 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ICHR broke above its upper Bollinger Band on April 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on May 04, 2026. You may want to consider a long position or call options on ICHR as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 181 cases where ICHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.705) is normal, around the industry mean (19.010). P/E Ratio (0.000) is within average values for comparable stocks, (126.813). Projected Growth (PEG Ratio) (0.746) is also within normal values, averaging (5.548). ICHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.007). P/S Ratio (2.553) is also within normal values, averaging (63.350).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment